역전사효소 억제제 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "역전사효소 억제제" in Korean language version.

refsWebsite

Global rank Korean rank

17nih.gov

4^th place

16doi.org

2^nd place

3^rd place

2harvard.edu

18^th place

27^th place

2archive.org

6^th place

18^th place

1semanticscholar.org

11^th place

310^th place

archive.org

Shafer, RW; Kozal, MJ; Winters, MA; Iversen, AK; Katzenstein, DA; Ragni, MV; Meyer Wa, 3rd; Gupta, P; 외. (1994). “Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations”. 《The Journal of Infectious Diseases》 169 (4): 722–9. doi:10.1093/infdis/169.4.722. PMID 8133086.
Maeda, Y; Venzon, DJ; Mitsuya, H (1998). “Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance”. 《The Journal of Infectious Diseases》 177 (5): 1207–13. doi:10.1086/515282. PMID 9593005.

doi.org

dx.doi.org

Hachiya, A; Kodama, EN; Schuckmann, MM; Kirby, KA; Michailidis, E; Sakagami, Y; Oka, S; Singh, K; Sarafianos, SG (2011). Ambrose, Zandrea, 편집. “K70Q adds high-level tenofovir resistance to "Q151M complex" HIV reverse transcriptase through the enhanced discrimination mechanism”. 《PLOS ONE》 6 (1): e16242. Bibcode:2011PLoSO...616242H. doi:10.1371/journal.pone.0016242. PMC 3020970. PMID 21249155.
Sarafianos, SG; Das, K; Clark Jr, AD; Ding, J; Boyer, PL; Hughes, SH; Arnold, E (1999). “Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids”. 《Proceedings of the National Academy of Sciences of the United States of America》 96 (18): 10027–32. Bibcode:1999PNAS...9610027S. doi:10.1073/pnas.96.18.10027. PMC 17836. PMID 10468556.
Shafer, RW; Kozal, MJ; Winters, MA; Iversen, AK; Katzenstein, DA; Ragni, MV; Meyer Wa, 3rd; Gupta, P; 외. (1994). “Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations”. 《The Journal of Infectious Diseases》 169 (4): 722–9. doi:10.1093/infdis/169.4.722. PMID 8133086.
Iversen, AK; Shafer, RW; Wehrly, K; Winters, MA; Mullins, JI; Chesebro, B; Merigan, TC (1996). “Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy”. 《Journal of Virology》 70 (2): 1086–90. doi:10.1128/JVI.70.2.1086-1090.1996. PMC 189915. PMID 8551567.
Maeda, Y; Venzon, DJ; Mitsuya, H (1998). “Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance”. 《The Journal of Infectious Diseases》 177 (5): 1207–13. doi:10.1086/515282. PMID 9593005.
Matsumi, S; Kosalaraksa, P; Tsang, H; Kavlick, MF; Harada, S; Mitsuya, H (2003). “Pathways for the emergence of multi-dideoxynucleoside-resistant HIV-1 variants”. 《AIDS》 17 (8): 1127–37. doi:10.1097/00002030-200305230-00003. PMID 12819513.
Meyer, PR; Matsuura, SE; Mian, AM; So, AG; Scott, WA (1999). “A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase”. 《Molecular Cell》 4 (1): 35–43. doi:10.1016/S1097-2765(00)80185-9. PMID 10445025.
Boyer, PL; Sarafianos, SG; Arnold, E; Hughes, SH (2001). “Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase”. 《Journal of Virology》 75 (10): 4832–42. doi:10.1128/JVI.75.10.4832-4842.2001. PMC 114238. PMID 11312355.
Arion, D; Kaushik, N; McCormick, S; Borkow, G; Parniak, MA (1998). “Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase”. 《Biochemistry》 37 (45): 15908–17. doi:10.1021/bi981200e. PMID 9843396.
De Clercq, E (1998). “The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection”. 《Antiviral Research》 38 (3): 153–79. doi:10.1016/S0166-3542(98)00025-4. PMID 9754886.
Das, Kalyan; Sarafianos, SG; Clark Jr, AD; Boyer, PL; Hughes, SH; Arnold, E (2007). “Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097”. 《J Mol Biol》 365 (1): 77–89. doi:10.1016/j.jmb.2006.08.097. PMID 17056061.
Hsiou, Y; Ding, J; Das, K; Clark Jr, AD; Boyer, PL; Lewi, P; Janssen, PA; Kleim, JP; 외. (2001). “The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance”. 《Journal of Molecular Biology》 309 (2): 437–45. doi:10.1006/jmbi.2001.4648. PMID 11371163.
Ren, J; Nichols, C; Bird, L; Chamberlain, P; Weaver, K; Short, S; Stuart, DI; Stammers, DK (2001). “Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors”. 《Journal of Molecular Biology》 312 (4): 795–805. doi:10.1006/jmbi.2001.4988. PMID 11575933.
Das, K; Ding, J; Hsiou, Y; Clark Jr, AD; Moereels, H; Koymans, L; Andries, K; Pauwels, R; 외. (1996). “Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant”. 《Journal of Molecular Biology》 264 (5): 1085–100. doi:10.1006/jmbi.1996.0698. PMID 9000632.
Hsiou, Y; Das, K; Ding, J; Clark Jr, AD; Kleim, JP; Rösner, M; Winkler, I; Riess, G; 외. (1998). “Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance”. 《Journal of Molecular Biology》 284 (2): 313–23. doi:10.1006/jmbi.1998.2171. PMID 9813120.
Ren, J; Esnouf, R; Garman, E; Somers, D; Ross, C; Kirby, I; Keeling, J; Darby, G; 외. (1995). “High resolution structures of HIV-1 RT from four RT-inhibitor complexes”. 《Nature Structural Biology》 2 (4): 293–302. doi:10.1038/nsb0495-293. PMID 7540934.

harvard.edu

adsabs.harvard.edu

Hachiya, A; Kodama, EN; Schuckmann, MM; Kirby, KA; Michailidis, E; Sakagami, Y; Oka, S; Singh, K; Sarafianos, SG (2011). Ambrose, Zandrea, 편집. “K70Q adds high-level tenofovir resistance to "Q151M complex" HIV reverse transcriptase through the enhanced discrimination mechanism”. 《PLOS ONE》 6 (1): e16242. Bibcode:2011PLoSO...616242H. doi:10.1371/journal.pone.0016242. PMC 3020970. PMID 21249155.
Sarafianos, SG; Das, K; Clark Jr, AD; Ding, J; Boyer, PL; Hughes, SH; Arnold, E (1999). “Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids”. 《Proceedings of the National Academy of Sciences of the United States of America》 96 (18): 10027–32. Bibcode:1999PNAS...9610027S. doi:10.1073/pnas.96.18.10027. PMC 17836. PMID 10468556.

nih.gov

ncbi.nlm.nih.gov

Claessens, Yann-Erick; Chiche, Jean-Daniel; Mira, Jean-Paul; Cariou, Alain (2003). “Bench-to-bedside review: Severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors”. 《Critical Care》. PMID 12793872.
Hachiya, A; Kodama, EN; Schuckmann, MM; Kirby, KA; Michailidis, E; Sakagami, Y; Oka, S; Singh, K; Sarafianos, SG (2011). Ambrose, Zandrea, 편집. “K70Q adds high-level tenofovir resistance to "Q151M complex" HIV reverse transcriptase through the enhanced discrimination mechanism”. 《PLOS ONE》 6 (1): e16242. Bibcode:2011PLoSO...616242H. doi:10.1371/journal.pone.0016242. PMC 3020970. PMID 21249155.
Sarafianos, SG; Das, K; Clark Jr, AD; Ding, J; Boyer, PL; Hughes, SH; Arnold, E (1999). “Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids”. 《Proceedings of the National Academy of Sciences of the United States of America》 96 (18): 10027–32. Bibcode:1999PNAS...9610027S. doi:10.1073/pnas.96.18.10027. PMC 17836. PMID 10468556.
Shafer, RW; Kozal, MJ; Winters, MA; Iversen, AK; Katzenstein, DA; Ragni, MV; Meyer Wa, 3rd; Gupta, P; 외. (1994). “Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations”. 《The Journal of Infectious Diseases》 169 (4): 722–9. doi:10.1093/infdis/169.4.722. PMID 8133086.
Iversen, AK; Shafer, RW; Wehrly, K; Winters, MA; Mullins, JI; Chesebro, B; Merigan, TC (1996). “Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy”. 《Journal of Virology》 70 (2): 1086–90. doi:10.1128/JVI.70.2.1086-1090.1996. PMC 189915. PMID 8551567.
Maeda, Y; Venzon, DJ; Mitsuya, H (1998). “Altered drug sensitivity, fitness, and evolution of human immunodeficiency virus type 1 with pol gene mutations conferring multi-dideoxynucleoside resistance”. 《The Journal of Infectious Diseases》 177 (5): 1207–13. doi:10.1086/515282. PMID 9593005.
Matsumi, S; Kosalaraksa, P; Tsang, H; Kavlick, MF; Harada, S; Mitsuya, H (2003). “Pathways for the emergence of multi-dideoxynucleoside-resistant HIV-1 variants”. 《AIDS》 17 (8): 1127–37. doi:10.1097/00002030-200305230-00003. PMID 12819513.
Meyer, PR; Matsuura, SE; Mian, AM; So, AG; Scott, WA (1999). “A mechanism of AZT resistance: an increase in nucleotide-dependent primer unblocking by mutant HIV-1 reverse transcriptase”. 《Molecular Cell》 4 (1): 35–43. doi:10.1016/S1097-2765(00)80185-9. PMID 10445025.
Boyer, PL; Sarafianos, SG; Arnold, E; Hughes, SH (2001). “Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase”. 《Journal of Virology》 75 (10): 4832–42. doi:10.1128/JVI.75.10.4832-4842.2001. PMC 114238. PMID 11312355.
Arion, D; Kaushik, N; McCormick, S; Borkow, G; Parniak, MA (1998). “Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase”. 《Biochemistry》 37 (45): 15908–17. doi:10.1021/bi981200e. PMID 9843396.
De Clercq, E (1998). “The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection”. 《Antiviral Research》 38 (3): 153–79. doi:10.1016/S0166-3542(98)00025-4. PMID 9754886.
Das, Kalyan; Sarafianos, SG; Clark Jr, AD; Boyer, PL; Hughes, SH; Arnold, E (2007). “Crystal structures of clinically relevant Lys103Asn/Tyr181Cys double mutant HIV-1 reverse transcriptase in complexes with ATP and non-nucleoside inhibitor HBY 097”. 《J Mol Biol》 365 (1): 77–89. doi:10.1016/j.jmb.2006.08.097. PMID 17056061.
Hsiou, Y; Ding, J; Das, K; Clark Jr, AD; Boyer, PL; Lewi, P; Janssen, PA; Kleim, JP; 외. (2001). “The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance”. 《Journal of Molecular Biology》 309 (2): 437–45. doi:10.1006/jmbi.2001.4648. PMID 11371163.
Ren, J; Nichols, C; Bird, L; Chamberlain, P; Weaver, K; Short, S; Stuart, DI; Stammers, DK (2001). “Structural mechanisms of drug resistance for mutations at codons 181 and 188 in HIV-1 reverse transcriptase and the improved resilience of second generation non-nucleoside inhibitors”. 《Journal of Molecular Biology》 312 (4): 795–805. doi:10.1006/jmbi.2001.4988. PMID 11575933.
Das, K; Ding, J; Hsiou, Y; Clark Jr, AD; Moereels, H; Koymans, L; Andries, K; Pauwels, R; 외. (1996). “Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant”. 《Journal of Molecular Biology》 264 (5): 1085–100. doi:10.1006/jmbi.1996.0698. PMID 9000632.
Hsiou, Y; Das, K; Ding, J; Clark Jr, AD; Kleim, JP; Rösner, M; Winkler, I; Riess, G; 외. (1998). “Structures of Tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance”. 《Journal of Molecular Biology》 284 (2): 313–23. doi:10.1006/jmbi.1998.2171. PMID 9813120.
Ren, J; Esnouf, R; Garman, E; Somers, D; Ross, C; Kirby, I; Keeling, J; Darby, G; 외. (1995). “High resolution structures of HIV-1 RT from four RT-inhibitor complexes”. 《Nature Structural Biology》 2 (4): 293–302. doi:10.1038/nsb0495-293. PMID 7540934.

semanticscholar.org

Hsiou, Y; Ding, J; Das, K; Clark Jr, AD; Boyer, PL; Lewi, P; Janssen, PA; Kleim, JP; 외. (2001). “The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance”. 《Journal of Molecular Biology》 309 (2): 437–45. doi:10.1006/jmbi.2001.4648. PMID 11371163.